Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based Advisor operating in the Health Care space. If you think a Advisor is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Zack Feather
Non Executive Advisor of RwHealth
Zack has worked in the healthcare sector for over 15 years. He was the founder of Asclepius Global.
Follow Zack Feather:
About RwHealth: RwHealth is a provider of healthcare ML and AI driven patient flow, predictive analytics and insights platform in the UK, US and AUZ.
Doug Oppenheim
Non Executive Director – Advisor of RwHealth
Doug is a Managing Partner of Fram Investment Partners. He moved into private equity in 2002 having previously worked at Dresdner Kleinwort Benson and Merrill Lynch. A significant proportion of Doug’s career has been focused on investing in and building businesses in healthcare. With interests spanning both the clinical and digital domains, Doug is passionate about the power of technology to transform both health outcomes and the affordability of care. He currently serves on the board of Healthcare at Home, which with 200,000 patients is the UK’s largest provider of complex clinical care in the home; he previously served on the board of Dedalus, one of Europe’s largest health software groups. Doug graduated from Cambridge University with first class honours. He has travelled extensively in the polar regions and has skied to the South Pole. He serves as Chairman of the British Exploring Society, a youth development charity established in 1932.
Follow Doug Oppenheim:
About RwHealth: RwHealth is a provider of healthcare ML and AI driven patient flow, predictive analytics and insights platform in the UK, US and AUZ.
Lopo Champalimaud
Advisor of Treatwell
Lopo is currently the CEO of Wahanda (http://www.wahanda.com), a London based health, beauty and wellness community & marketplace that connects consumers, wellness businesses and professionals through content, ratings & reviews and commerce. Lopo co-founded Wahanda with Salim Mitha in February 2008. Prior to Wahanda, Lopo was the Managing Director of European Lifestyle for lastminute.com. In this role he was responsible for developing all aspects of the non-travel business across Europe at lastminute.com which included Theatre ticketing, concert ticketing, restaurant bookings, days out, experiences and spas. Lopo joined lastminute.com in January 2004 and when he left to found Wahanda, lifestyle respresented more than 40% of all the sales by volume at the company. From 1994 to 2004, Lopo was the Co-Founder and Managing Director of Fulcrum Analytics (http://www.fulcrumanalytics.com). Fulcrum is today one of the leading database marketing firms in North America but was initially known as Cyber Dialogue and was the world’s first online market research firm. Cyber Dialogue is credited with having created the online survey, the online focus group while providing industry leading insight on the internet consumer.
Follow Lopo Champalimaud:
About Treatwell: Treatwell is Europe’s leading marketplace for booking hair and beauty appointments online.
Tim Carter
Advisor Brand and Marketing of Baby2Body
Follow Tim Carter:
About : Baby2Body is a fully automated health, fitness and wellbeing coaching platform for pregnant women and mothers.
Nick Tong
Technical Advisor of Unmind
Often referred to as a “geek that can speak” Nick is a technologist with engaging communications skills. He is an entrepreneur with specialist experience in management information systems and product innovation. With other 15 years of technical experience Nick has worked with brands such as the NHS, Courvoisier, RSPCA, Publicis, Vodafone, Fixnetix, HomeTrack and the BBC. Nick has gained an exceptional ability in interpreting technology enablers and formulating digital strategies to fulfil business objectives. His experience includes: CTO and Co-Founder of Compare and Share, the worlds 1st marketplace focussing on the Sharing Economy; and founder of Tizuni Digital a full service digital agency specialising in information systems and product development.
Follow Nick Tong:
About SkillSnap, Unmind: Unmind is a B2B mental health platform providing clinically-backed tools and training.
Andrew Rice
Scientific Advisor of Spinifex Pharmaceuticals
Andrew is Professor of Pain Research at Imperial College London and Honorary Consultant in Pain Medicine at Chelsea and Westminster Hospital. He undertakes research and clinical practice in neuropathic pain, focussing on post herpetic neuralgia, peripheral nerve injury and HIV neuropathy. Andrew received his medical degree from the St. Mary’s Hospital Medical School in 1982 and his research doctorate from the St. Thomas’ Hospital Medical School (UMDS) in 1991. He underwent his specialist clinical training mainly in Oxford and at St Thomas’ Hospital, London. He is an author of more than 90 scientific publications, sits on the editorial boards of Pain and PLoS–Medicine and is lead editor of the four volume “Textbook of Clinical Pain Management”. He is currently Chair-elect (previously Secretary) of the International Association for the Study of Pain Special Interest Group on Neuropathic Pain (www.neupsig.org). Andrew is Administrative Director of the Wellcome Trust funded London Pain Consortium (www.lpc.ac.uk) and the academic lead for the animal models work package on the EU Innovative Medicines Initiative grant “Europain”. He is also the link person between Europain and the corresponding US Food and Drugs Administration Critical Path Initiative: Analgesic Clinical Trial Innovations, Opportunities and Networks (ACTION). He was the Michael Cousins lecturer at the Australian and New Zealand College of Anaesthetists (2009) and Covino Lecturer at Harvard University (2008).Andrew led the protocol development team for the Phase 2 clinical trial of EMA401 in post herpetic neuralgia patients and, given his clinical leadership in the area of neuropathic pain, helps guide the overall development of EMA401.
Follow Andrew Rice:
About Chelsea and Westminster Hospital, Imperial College London, The London Pain Consortium: Spinifex Pharmaceuticals is a clinical-stage biotechnology company specializing in the development of products for the treatment of pain.
Praveen Anand
Scientific Advisor of Spinifex Pharmaceuticals
Praveen is Professor of Clinical Neurology at Imperial College London, based at Hammersmith Hospital. His medical education was at the Universities of Oxford and Cambridge, UK, and post-graduate training was at the Hammersmith Hospital and the National Hospital for Neurology and Neurosurgery, Queen Square, London. His research focuses on pathophysiological and molecular mechanisms in the human sensory neuropathies and chronic pain syndromes. Collaborations with pharmaceutical companies are directed to translational projects and new techniques which bridge the gap between pre-clinical developments and successful clinical applications. The techniques of assessment have included contact heat evoked potentials (CHEPS) and molecular markers in skin biopsies. Clinical trials have been conducted using novel compounds for pain and nerve regeneration with several companies, including GlaxoSmithKline, Genentech, Roche, and Amgen. He has over 150 peer reviewed publications in journals including Nature, Nature Medicine, Nature Genetics, The Lancet, and Science.Praveen is conducting fundamental pharmacology studies on the AT2 receptor in human tissue as well as providing clinical leadership into the Phase 2 program for EMA401.
Follow Praveen Anand:
About Imperial College London: Spinifex Pharmaceuticals is a clinical-stage biotechnology company specializing in the development of products for the treatment of pain.
Alan Naylor
Scientific Advisor of Spinifex Pharmaceuticals
Follow Alan Naylor:
About Pathios Therapeutics: Spinifex Pharmaceuticals is a clinical-stage biotechnology company specializing in the development of products for the treatment of pain.
Mark Critchley
Investor & Advisor of MysteryVibe
Follow Mark Critchley:
About Backpain Help, Handsome: Award Winning Sexual Health Products. Deeply researched, anatomically designed, doctor-endorsed products to make intimacy easy.
Richard Girling
Advisor of Hikma Ventures
Follow Richard Girling:
About : Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals.
Asaf Homossany
Advisor of TalkLife
Follow Asaf Homossany:
About Nasdaq: The Social Network That Saves Lives
Peter Dobson
Advisor of Adaptix Ltd
Follow Peter Dobson:
About : Adaptix is transforming planar X-ray – the diagnostic imaging modality most widely used in healthcare worldwide.
Peter Dobson
Advisor of Adaptix Ltd
Follow Peter Dobson:
About : Adaptix is transforming planar X-ray – the diagnostic imaging modality most widely used in healthcare worldwide.
Raphael Hauser
Advisor of Adaptix Ltd
Follow Raphael Hauser:
About : Adaptix is transforming planar X-ray – the diagnostic imaging modality most widely used in healthcare worldwide.
Michael Cohrs
Advisor of Harbor Biometrics
Follow Michael Cohrs:
About : We make FirstID, the private vital health registry enabling emergency care providers to access life and cost saving info via biometric ID.
Chris Jones
Non Executive Director & Special Advisor of MediSieve
Chris Jones joined Elasmogen as Executive Chairman in 2016.
Follow Chris Jones:
About Elasmogen, MediSieve, Mologic: MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.
Debasish Talukdar
President, Global Head of Advisory of Prescient Healthcare Group
Follow Debasish Talukdar:
About Prescient Healthcare Group: Prescient Healthcare Group was founded in London in 1995, originally specializing in competitive insights.
Jake Arnold-Forster
Business Advisor of MIRA Rehab
Follow Jake Arnold-Forster:
About MIRA Rehab: Digital Health Company that is Gamifying Physiotherapy and Transforming Rehabilitation.
Bibhas Roy
Clinical Advisor of MIRA Rehab
Follow Bibhas Roy:
About MIRA Rehab: Digital Health Company that is Gamifying Physiotherapy and Transforming Rehabilitation.
Bibhas Roy
Clinical Advisor of MIRA Rehab
Follow Bibhas Roy:
About MIRA Rehab: Digital Health Company that is Gamifying Physiotherapy and Transforming Rehabilitation.
Toks Oyegunle
Advisor of OaCP
Follow Toks Oyegunle:
About : OaCP reduces cancer’ genetic tests time from 3 days to 2 hours and the cost by 50% with its chemical reagents.
Tony Sedgwick
Life Science Advisor of Blueberry Therapeutics
Tony Sedgwick is life Science Advisor at Blueberry Therapeutics.
Follow Tony Sedgwick:
About : Blueberry Therapeutics focuses on developing medicines for inflammatory and infectious diseases.
Eleanor Howat
Senior Policy Advisor – Health Inequalities (Learning Disabilities) and LeDeR of Department of Health and Social Care (DHSC)
Follow Eleanor Howat:
About Department of Health and Social Care (DHSC): Department of Health and Social Care (DHSC) is a department of Majesty’s Government
Bob Clay
Senior Regulatory Advisor of Precision Medicines
Bob has over 30 years experience in drug development at AstraZeneca, Pfizer, Wellcome & Zambon. Bob served as Vice President of Global Regulatory Affairs at AstraZeneca with responsibility for oncology, infection, and personalised healthcare. Bob supported the development and approval of 16 drugs including cancer medicines Lynparza, Iressa and Caprelsa. Bob received his degree in Pharmacy from the University of Bath, MSc in BioPharmacy from the University of London and an MBA from the Open University.
Follow Bob Clay:
About : Precision Medicines is dedicated to improving the lives of cancer patients through developing novel targeted medicines.
Nada Savitch
Advisor of See What I Mean
Nada has a background in information work and worked as website manager for the Alzheimer’s Society for almost six years. During this time she provided support and training to groups of people with dementia who were interested in using computers. She also worked on a consultation basis with people with dementia to design websites and to develop new and accessible computer software.
Follow Nada Savitch:
About : See What I Mean is a speech to image communication tool that translates words into pictures.
Saif Abed
Founding Partner and Director of Cybersecurity Advisory Services of AbedGraham Healthcare Strategies
Saif Abed is the CEO of Clinical Cyber Defense Systems. He is also the founding partner and director of cybersecurity advisory services at AbedGraham.
Follow Saif Abed:
About AbedGraham Healthcare Strategies: Exclusively clinically based, healthcare IT strategy consultancy providing clinical analysis, strategy development, and risk compliance
Jag Ahulawalia
Chief Clinical Advisor of Charco Neurotech
Jag Ahulawalia is the Chief Clinical Advisor at Charco Neurotech.
Follow Jag Ahulawalia:
About Charco Neurotech: Charco Neurotech is a medical technology company that develops non-invasive wearable devices.
Prof Fergus Gleeson FRCP FRCR
Chair, Medical Advisory Board of Optellum
Follow Prof Fergus Gleeson FRCP FRCR:
About : Optellum develops an imaging biomarker for smart lung cancer detection.
Prof Andrew Zisserman FRS
Scientific Advisory Board Member of Optellum
Follow Prof Andrew Zisserman FRS:
About : Optellum develops an imaging biomarker for smart lung cancer detection.
Andy Lavendar
Activated Patient Advisor of Elemental Software
Andy Lavendar is the Chairman at Sentireal.
Follow Andy Lavendar:
About Acumensis, Elemental Software: Elemental is a digital platform that connects patients health and social care professionals and community health & wellness providers.
Nicholas Lakin
Vice President, Advisory Services of Kinapse
Follow Nicholas Lakin:
About Kinapse: Kinapse provides advisory, capability building and operational services to the life sciences industries.
